212 related articles for article (PubMed ID: 32429174)
1. Characterization of Stem-like Circulating Tumor Cells in Pancreatic Cancer.
Zhu L; Hissa B; Győrffy B; Jann JC; Yang C; Reissfelder C; Schölch S
Diagnostics (Basel); 2020 May; 10(5):. PubMed ID: 32429174
[TBL] [Abstract][Full Text] [Related]
2. The Crosstalk Between Immune Infiltration, Circulating Tumor Cells, and Metastasis in Pancreatic Cancer: Identification of HMGB3 From a Multiple Omics Analysis.
Tang HD; Wang Y; Xie P; Tan SY; Li HF; Shen H; Zhang Z; Lei ZQ; Zhou JH
Front Genet; 2022; 13():892177. PubMed ID: 35754798
[TBL] [Abstract][Full Text] [Related]
3. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of circulating tumor cells in pancreatic ductal adenocarcinoma: potential diagnostic and prognostic significance in clinical practice.
Zhao X; Ma Y; Dong X; Zhang Z; Tian X; Zhao X; Yang Y
Hepatobiliary Surg Nutr; 2021 Dec; 10(6):796-810. PubMed ID: 35004946
[TBL] [Abstract][Full Text] [Related]
5. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling.
Zhang Z; Xu Y
Mol Med; 2022 Jul; 28(1):82. PubMed ID: 35854234
[TBL] [Abstract][Full Text] [Related]
6. Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival.
Amantini C; Morelli MB; Nabissi M; Piva F; Marinelli O; Maggi F; Bianchi F; Bittoni A; Berardi R; Giampieri R; Santoni G
Front Oncol; 2019; 9():874. PubMed ID: 31552188
[TBL] [Abstract][Full Text] [Related]
7. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
[TBL] [Abstract][Full Text] [Related]
8. GAS2L1 Is a Potential Biomarker of Circulating Tumor Cells in Pancreatic Cancer.
Zhu L; Kan KJ; Grün JL; Hissa B; Yang C; Győrffy B; Loges S; Reißfelder C; Schölch S
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33333841
[TBL] [Abstract][Full Text] [Related]
9. Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients.
Nitschke C; Markmann B; Tölle M; Kropidlowski J; Belloum Y; Goetz MR; Schlüter H; Kwiatkowski M; Sinn M; Izbicki J; Pantel K; Güngör C; Uzunoglu FG; Wikman H
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139565
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-Mesenchymal-Transition-Like Circulating Tumor Cell-Associated White Blood Cell Clusters as a Prognostic Biomarker in HR-Positive/HER2-Negative Metastatic Breast Cancer.
Guan X; Li C; Li Y; Wang J; Yi Z; Liu B; Chen H; Xu J; Qian H; Xu B; Ma F
Front Oncol; 2021; 11():602222. PubMed ID: 34150608
[TBL] [Abstract][Full Text] [Related]
11. CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients.
Sun Y; Wu G; Cheng KS; Chen A; Neoh KH; Chen S; Tang Z; Lee PF; Dai M; Han RPS
EBioMedicine; 2019 Aug; 46():133-149. PubMed ID: 31375425
[TBL] [Abstract][Full Text] [Related]
12. Portal Venous Circulating Tumor Cells Undergoing Epithelial-Mesenchymal Transition Exhibit Distinct Clinical Significance in Pancreatic Ductal Adenocarcinoma.
Pan Y; Li D; Yang J; Wang N; Xiao E; Tao L; Ding X; Sun P; Li D
Front Oncol; 2021; 11():757307. PubMed ID: 34778073
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
14. KRAS mutations in pancreatic circulating tumor cells: a pilot study.
Kulemann B; Liss AS; Warshaw AL; Seifert S; Bronsert P; Glatz T; Pitman MB; Hoeppner J
Tumour Biol; 2016 Jun; 37(6):7547-54. PubMed ID: 26684803
[TBL] [Abstract][Full Text] [Related]
15. Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal Adenocarcinoma.
Tang R; Liu X; Wang W; Hua J; Xu J; Liang C; Meng Q; Liu J; Zhang B; Yu X; Shi S
Front Oncol; 2021; 11():643465. PubMed ID: 33912458
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells.
Yeo D; Bastian A; Strauss H; Saxena P; Grimison P; Rasko JEJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163592
[TBL] [Abstract][Full Text] [Related]
17. Spatial heterogeneity in epithelial to mesenchymal transition properties of circulating tumor cells associated with distant recurrence in pancreatic cancer patients.
Dong X; Ma Y; Zhao X; Tian X; Sun Y; Yang Y; Zhao X
Ann Transl Med; 2020 Jun; 8(11):676. PubMed ID: 32617296
[TBL] [Abstract][Full Text] [Related]
18. Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer.
Papadaki MA; Stoupis G; Theodoropoulos PA; Mavroudis D; Georgoulias V; Agelaki S
Mol Cancer Ther; 2019 Feb; 18(2):437-447. PubMed ID: 30401696
[TBL] [Abstract][Full Text] [Related]
19. Krüppel-like factor 10 modulates stem cell phenotypes of pancreatic adenocarcinoma by transcriptionally regulating notch receptors.
Tsai YC; Cheng KH; Jiang SS; Hawse JR; Chuang SE; Chen SL; Huang TS; Ch'ang HJ
J Biomed Sci; 2023 Jun; 30(1):39. PubMed ID: 37308977
[TBL] [Abstract][Full Text] [Related]
20. Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.
Mu Z; Benali-Furet N; Uzan G; Znaty A; Ye Z; Paolillo C; Wang C; Austin L; Rossi G; Fortina P; Yang H; Cristofanilli M
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27706044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
